β-blockers in heart failure: Clinical applications

Michael H. Farrell, Joanne Micale Foody, Harlan M. Krumholz

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

β-Blockers reduce morbidity and mortality in heart failure patients with left ventricular systolic dysfunction and stable fluid status. The successful adoption of β-blocker guidelines for these patients requires an understanding of the value of this therapy and effective systems to maintain safety and ensure high quality of care. This article distills scientific evidence and consensus guidelines into a series of cases and practical answers about patient selection, discussions with patients, management and monitoring, and systems improvements to optimize quality of care, safety, and benefit for all patients with heart failure.

Original languageEnglish (US)
Pages (from-to)890-897
Number of pages8
JournalJournal of the American Medical Association
Volume287
Issue number7
DOIs
StatePublished - Feb 20 2002
Externally publishedYes

Fingerprint Dive into the research topics of 'β-blockers in heart failure: Clinical applications'. Together they form a unique fingerprint.

Cite this